Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 12/20 | 0.53 |
| ▸ | PIK3CB | P42338 | 18/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 8/20 | 0.44 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15029815 | 1.00 | PIK3CD (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL16308187 | 1.00 | PIK3CD (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL16309715 | 1.00 | PIK3CD (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL15009086 | 0.92 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL15009445 | 0.92 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL15009082 | 0.92 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL15009449 | 0.92 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL16308236 | 0.89 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL15029986 | 0.89 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 | |
| SCHEMBL15029987 | 0.89 | PIK3CB (0.53) | PIK3CDPIK3CBPIK3CAPIK3CGPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130150364-A1 | HETEROCYCLIC COMPOUND | ASTELLAS PHARMA INC. (JP) | 2013-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150364-A1 | HETEROCYCLIC COMPOUND | IL2, NFATC1, ICOS | PIK3CD 6/4885PIK3CB 16/4885PIK3CA 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.